Filing Details
- Accession Number:
- 0001209191-18-057190
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-05 16:38:16
- Reporting Period:
- 2018-11-01
- Accepted Time:
- 2018-11-05 16:38:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
924717 | Surmodics Inc | SRDX | Surgical & Medical Instruments & Apparatus (3841) | 411356149 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1508798 | R Gary Maharaj | 9924 West 74Th Street Eden Prairie MN 55344 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-11-01 | 4,193 | $62.13 | 166,086 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-11-01 | 807 | $62.64 | 165,279 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018.
- Reflects the weighted average price of 4,193 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on November 1, 2018 with sale prices ranging from $61.50 to $62.43 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average price of 807 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on November 1, 2018 with sale prices ranging from $62.51 to $63.085 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.